Evaluation of Allergic Diseases, Symptom Control, and Relation to Infections in a Group of Italian Elite Mountain Bikers.


Journal

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine
ISSN: 1536-3724
Titre abrégé: Clin J Sport Med
Pays: United States
ID NLM: 9103300

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 27 10 2018
medline: 24 4 2021
entrez: 27 10 2018
Statut: ppublish

Résumé

This study estimates the prevalence of allergic diseases in a group of Italian elite mountain bikers, compares the prevalence of infectious episodes between allergic and nonallergic athletes, and evaluates asthma and rhinitis symptom control in allergic athletes. Two hundred twenty-six Italian nonsmoking mountain bikers received by mail the Allergy Questionnaire for Athletes (AQUA) and completed it. The RhinAsthma Patient Perspective (RAPP) questionnaire was sent to the 108 participants with a positive AQUA score and 104 returned the questionnaire. Athletes with an AQUA score ≥5 or <5 were defined AQUA+ (allergic) or AQUA- (nonallergic), respectively. RhinAsthma Patient Perspective questionnaire total score ≥15 was indicative of a poor control of symptoms. Of the 226 athletes, 47.8% were AQUA+, whereas 52.2% were AQUA-. A higher number of AQUA+ athletes reported frequent upper respiratory tract infections (URTIs) and herpes labialis than AQUA- athletes (P < 0.001), and the prevalence of URTI was greater in the subgroup of AQUA+ athletes who trained ≥3 hours per session. According to RAPP questionnaire score, 21.1% of AQUA+ mountain bikers had a poor control of asthma and rhinitis symptoms. Our study shows a high prevalence of allergy among Italian elite mountain bikers whose asthma and rhinitis symptoms are poorly controlled in about a fifth of the sample. Allergic athletes, mainly those training more than 3 hours per session, are at higher risk of URTI and herpes labialis. Screening programs to detect allergic diseases and to evaluate symptom control in athletes should be strongly encouraged.

Identifiants

pubmed: 30365469
doi: 10.1097/JSM.0000000000000678
pii: 00042752-202009000-00006
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

465-469

Références

Thomas S, Wolfarth B, Wittmer C, et al. Self-reported asthma and allergies in top athletes compared to the general population - results of the German part of the GA2LEN-Olympic study 2008. Allergy Asthma Clin Immunol. 2010;6:31.
Passali D, Damiani V, Passali GC, et al. Alterations in rhinosinusal homeostasis in a sportive population: our experience with 106 athletes. Eur Arch Otorhinolaryngol. 2004;261:502–506.
Surda P, Walker A, Putala M, et al. Prevalence of rhinitis in athletes: systematic review. Int J Otolaryngol. 2017;2017:1–5.
Helenius IJ, Tikkanen HO, Haahtela T. Association between type of training and risk of asthma in elite athletes. Thorax. 1997;52:157–160.
Fitch KD. An overview of asthma and airway hyper-responsiveness in Olympic athletes. Br J Sports Med. 2012;46:413–416.
Bonini M, Gramiccioni C, Fioretti D, et al. Asthma, allergy and the Olympics: a 12-year survey in elite athletes. Curr Opin Allergy Clin Immunol. 2015;15:184–192.
Bonini M, Braido F, Baiardini I, et al. AQUA: allergy questionnaire for athletes. Development and validation. Med Sci Sports Exerc. 2009;41:1034–1041.
Hosey RG, Rodenberg RE. Training room management of medical conditions: infectious diseases. Clin Sports Med. 2005;24:477–506, vii.
Kostka T, Berthouze SE, Lacour J, et al. The symptomatology of upper respiratory tract infections and exercise in elderly people. Med Sci Sports Exerc. 2000;32:46–51.
Longobardi L. Bronchial asthma in the elderly patient. J Gerontol Geriatr. 2016;64:55–65.
Iadevaia C, Iacotucci P, Carnovale V, et al. Incidental late diagnosis of cystic fibrosis following AH1N1 influenza virus pneumonia : a case report. J Med Case Rep. 2017;11:278.
Peters EM, Bateman ED. Ultramarathon running and upper respiratory tract infections: an epidemiological survey. S Afr Med J. 1983;64:582–584.
Peters EM, Anderson R, Theron AJ. Attenuation of increase in circulating cortisol and enhancement of the acute phase protein response in vitamin C-supplemented ultramarathoners. Int J Sports Med. 2001;22:120–126.
Spence L, Brown WJ, Pyne DB, et al. Incidence, etiology, and symptomatology of upper respiratory illness in elite athletes. Med Sci Sports Exerc. 2007;39:577–586.
Larsson K, Ohlsén P, Larsson L, et al. High prevalence of asthma in cross country skiers. BMJ. 1993;307:1326–1329.
Bougault V, Turmel J, St-Laurent J, et al. Asthma, airway inflammation and epithelial damage in swimmers and cold-air athletes. Eur Respir J. 2009;33:740–746.
Lichaba M. Respiratory tract symptoms in endurance athletes—a review of causes and consequences. Curr Allergy Clin Immunol. 2010;23:52–57.
Perry C, Pick M, Bdolach N, et al. Endurance exercise diverts the balance between Th17 cells and regulatory T cells. PLoS One. 2013;8:e74722.
Gleeson M, Pyne DB. Respiratory inflammation and infections in high-performance athletes. Immunol Cell Biol. 2016;94:124–131.
Robson-Ansley P, Howatson G, Tallent J, et al. Prevalence of allergy and upper respiratory tract symptoms in runners of the London marathon. Med Sci Sports Exerc. 2012;44:999–1004.
Brozek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140:950–958.
Marchetti P, Pesce G, Villani S, et al. Pollen concentrations and prevalence of asthma and allergic rhinitis in Italy: evidence from the GEIRD study. Sci Total Environ. 2017;584-585:1093–1099.
Braido F, Baiardini I, Stagi E, et al. RhinAsthma patient perspective: a short daily asthma and rhinitis QoL assessment. Allergy. 2012;67:1443–1450.
Teixeira RN, Mendes FA, Martins MA, et al. AQUA as predictor of allergy in elite marathon runners. World Allergy Organ J. 2014;7:7.
Katelaris CH, Carrozzi FM, Burke TV. Allergic rhinoconjunctivitis in elite athletes: optimal management for quality of life and performance. Sports Med. 2003;33:401–406.
Carlsen KH. Asthma, airway inflammation and epithelial damage in elite athletes. Eur Respir J. 2009;33:713–714.
Gleeson M. Mucosal immune responses and risk of respiratory illness in elite athletes. Exerc Immunol Rev. 2000;6:5–42.
Dijkstra HP, Robson-Ansley P. The prevalence and current opinion of treatment of allergic rhinitis in elite athletes. Curr Opin Allergy Clin Immunol. 2011;11:103–108.
Ahmadinejad Z, Alijani N, Mansori S, et al. Common sports-related infections: a review on clinical pictures, management and time to return to sports. Asian J Sports Med. 2014;5:1–9.
Nieman DC. Is infection risk linked to exercise workload? Med Sci Sports Exerc. 2000;32(7 suppl):S406–S411.
Nieman DC. Exercise, upper respiratory tract infection, and the immune system. Med Sci Sports Exerc. 1994;26:128–139.
Carlsen KH, Anderson SD, Bjermer L, et al. Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the joint task force of European Respiratory Society (ERS) and European Academy of Allergy And Clinical Immunology. Allergy. 2008;63:492–505.
Armstrong R, Waters E, Doyle J. Reviews in Health Promotion and Public Health, Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration; 2008.

Auteurs

Fabio Perrotta (F)

Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli," Naples, Italy.

Vittorio Simeon (V)

Department of Mental Health and Public Medicine, Section of Statistics, University of Campania "Luigi Vanvitelli," Naples, Italy.

Matteo Bonini (M)

National Heart and Lung Institute, Royal Brompton Hospital & Imperial College, London, United Kingdom.

Luigi Ferritto (L)

Department of Internal Medicine, Clinica Athena-Villa dei Pini, Piedimonte Matese, Caserta, Italy.

Laura Arenare (L)

IOS Coleman, Acerra, Naples, Italy; and.

Ersilia Nigro (E)

CEINGE-Biotecnologie Avanzate S.c.a r.l., Napoli, Italy.

Ambra Nicolai (A)

Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli," Naples, Italy.

Aurora Daniele (A)

CEINGE-Biotecnologie Avanzate S.c.a r.l., Napoli, Italy.

Cecilia Calabrese (C)

Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli," Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH